Insider transaction feed
Latest SEC Form 4 insider trades with explainable signal scoring.
12,344 transactions Export CSV
Buy volume
$1.64B
7007 buy transactions
Sell volume
$15.99B
5337 sell transactions
Net flow
-$14.35B
Net selling
Total flow
$17.63B
12344 priced transactions
Net insider flow· last 30 days
Buys Sellsnet -$14.61B
Convergence— where independent disclosures line up
View all signals →
| Transaction | Flags | ||||||||
|---|---|---|---|---|---|---|---|---|---|
10d ago Jun 29, 2026 | GALECTIN THERAPEUTICS INC | Jamil Khurram Chief Medical Officer | Buy · M | 47,467 | $0.00 | $0 | Neutral+3 | 10b5-1Deriv | |
10d ago Jun 26, 2026 | GALECTIN THERAPEUTICS INC | Jamil Khurram Chief Medical Officer | Buy · M | 2,533 | $0.00 | $0 | Neutral+3 | 10b5-1Deriv | |
10d ago Jun 26, 2026 | GALECTIN THERAPEUTICS INC | Jamil Khurram Chief Medical Officer | Buy · M | 2,037 | $0.00 | $0 | Neutral+3 | 10b5-1Deriv | |
10d ago Jun 29, 2026 | GALECTIN THERAPEUTICS INC | Jamil Khurram Chief Medical Officer | Sell · S | 47,467 | $5.04 | $239.2K | Neutral+3 | 10b5-1 | |
10d ago Jun 29, 2026 | GALECTIN THERAPEUTICS INC | Jamil Khurram Chief Medical Officer | Buy · M | 47,467 | $2.50 | $118.7K | Neutral+3 | 10b5-1 | |
10d ago Jun 26, 2026 | GALECTIN THERAPEUTICS INC | Jamil Khurram Chief Medical Officer | Sell · S | 2,533 | $5.00 | $12.7K | Neutral+3 | 10b5-1 | |
10d ago Jun 26, 2026 | GALECTIN THERAPEUTICS INC | Jamil Khurram Chief Medical Officer | Buy · M | 2,533 | $2.50 | $6.3K | Neutral+3 | 10b5-1 | |
10d ago Jun 26, 2026 | GALECTIN THERAPEUTICS INC | Jamil Khurram Chief Medical Officer | Sell · S | 2,037 | $5.00 | $10.2K | Neutral+3 | 10b5-1 | |
10d ago Jun 26, 2026 | GALECTIN THERAPEUTICS INC | Jamil Khurram Chief Medical Officer | Buy · M | 2,037 | $2.20 | $4.5K | Neutral+3 | 10b5-1 | |
10d ago Jun 29, 2026 | PARK OHIO HOLDINGS CORP | CRAWFORD MATTHEW V CEO, COB, President · Director · 10% Owner | Sell · F | 13,199 | $39.06 | $515.6K | Neutral+8 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Mitchell H Elizabeth Director | Buy · A | 80 | $0.00 | $0 | Neutral+2 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | RIVERA ALFREDO Director | Buy · A | 25 | $107.75 | $2.7K | Neutral+2 | Deriv | |
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | RIVERA ALFREDO Director | Buy · A | 117 | $0.00 | $0 | Neutral+2 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Richer Clare Stack Director | Buy · A | 142 | $0.00 | $0 | Neutral+2 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Pickerell Blair Director | Buy · A | 281 | $0.00 | $0 | Neutral+2 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Nordin Diane C Director | Buy · A | 217 | $0.00 | $0 | Neutral+2 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Muruzabal Claudio Director | Buy · A | 100 | $0.00 | $0 | Neutral+2 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Mills Scott Director | Buy · A | 152 | $107.75 | $16.4K | Neutral+2 | Deriv | |
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Mills Scott Director | Buy · A | 253 | $0.00 | $0 | Neutral+2 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | HOCHSCHILD ROGER C Director | Buy · A | 219 | $107.75 | $23.6K | Neutral+2 | Deriv | |
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | HOCHSCHILD ROGER C Director | Buy · A | 294 | $0.00 | $0 | Neutral+2 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Carter Miller Jocelyn Director | Buy · A | 669 | $0.00 | $0 | Neutral+2 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Beams Mary E. Director | Buy · A | 109 | $0.00 | $0 | Neutral+2 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Auerbach Jonathan Director | Buy · A | 166 | $0.00 | $0 | Neutral+2 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Pitz Joel EVP & CFO | Buy · A | 2 | $0.00 | $0 | Neutral+5 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Pitz Joel EVP & CFO | Buy · A | 234 | $0.00 | $0 | Neutral+5 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Bhatia Kamal President and CEO - PAM | Buy · A | 430 | $0.00 | $0 | Neutral+5 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | LITTLEFIELD CHRISTOPHER J President - RIS | Buy · A | 559 | $0.00 | $0 | Neutral+5 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Kay Kathleen B EVP-Chief Information Officer | Buy · A | 398 | $0.00 | $0 | Neutral+5 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Friedrich Amy Christine President - Benefits & Protect | Buy · A | 599 | $0.00 | $0 | Neutral+5 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Cheong Wee Yee President - Asia & Middle East | Buy · A | 368 | $0.00 | $0 | Neutral+5 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | Agrawal Vivek EVP & Chief Growth Officer | Buy · A | 234 | $0.00 | $0 | Neutral+5 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | STRABLE-SOETHOUT DEANNA D Chair, President and CEO | Buy · A | 44 | $0.00 | $0 | Neutral+5 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | STRABLE-SOETHOUT DEANNA D Chair, President and CEO | Buy · A | 612 | $0.00 | $0 | Neutral+5 | ||
10d ago Jun 26, 2026 | PRINCIPAL FINANCIAL GROUP INC | McCullum Kenneth A. EVP - Chief Risk Officer | Buy · A | 73 | $0.00 | $0 | Neutral+5 | ||
10d ago Jun 10, 2026 | GYRE THERAPEUTICS, INC. | Carmichael Gordon Director | Buy · A | 40,000 | $0.00 | $0 | Neutral0 | LateDeriv | |
10d ago Jun 10, 2026 | GYRE THERAPEUTICS, INC. | Epstein David M. Director | Buy · A | 40,000 | $0.00 | $0 | Neutral0 | LateDeriv | |
10d ago Jun 10, 2026 | GYRE THERAPEUTICS, INC. | Weng Dan Director | Buy · A | 40,000 | $0.00 | $0 | Neutral0 | LateDeriv | |
10d ago Jun 10, 2026 | GYRE THERAPEUTICS, INC. | Parry Renate Director | Buy · A | 40,000 | $0.00 | $0 | Neutral0 | LateDeriv | |
10d ago Jun 10, 2026 | GYRE THERAPEUTICS, INC. | Zhang Ping Director | Buy · A | 40,000 | $0.00 | $0 | Neutral0 | LateDeriv | |
10d ago Jun 10, 2026 | GYRE THERAPEUTICS, INC. | Nussbaum Rodney L Director | Buy · A | 40,000 | $0.00 | $0 | Neutral0 | LateDeriv | |
10d ago Jun 26, 2026 | ORASURE TECHNOLOGIES INC | Boyd Steven Kyle Director | Buy · A | 3,666 | $4.43 | $16.2K | Neutral+2 | ||
10d ago Jun 26, 2026 | Wheeler Real Estate Investment Trust, Inc. | Stilwell Joseph Director · 10% Owner | Sell · S | 13,895 | $8.64 | $120.1K | Mild sell-15 | Deriv | |
10d ago Jun 26, 2026 | Wheeler Real Estate Investment Trust, Inc. | Stilwell Joseph Director · 10% Owner | Sell · S | 11,105 | $8.64 | $96.0K | Mild sell-15 | Deriv | |
10d ago Jun 26, 2026 | TEREX CORP | OCONNELL MAUREEN Director | Buy · A | 1,880 | $71.81 | $135.0K | Neutral+2 | ||
10d ago Jun 29, 2026 | Worthington Steel, Inc. | BLYSTONE JOHN B Executive Chairman · Director | Sell · F | 7,414 | $35.16 | $260.7K | Neutral+6 | ||
10d ago Jun 26, 2026 | Worthington Steel, Inc. | BLYSTONE JOHN B Executive Chairman · Director | Buy · A | 14,665 | $0.00 | $0 | Neutral+6 | ||
10d ago Jun 29, 2026 | NetEase, Inc. | Boltz Paul William JR General Counsel | Sell · S | 10,000 | $128.30 | $1.28M | Mild sell-22 | ||
10d ago Jun 30, 2026 | COMMUNITY HEALTH SYSTEMS INC | Krishnan K Ranga Director | Buy · M | 13,931 | $0.00 | $0 | Neutral+2 | Deriv | |
10d ago Jun 30, 2026 | COMMUNITY HEALTH SYSTEMS INC | Krishnan K Ranga Director | Buy · M | 13,930 | $0.00 | $0 | Neutral+2 |
